iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Trading Up 2% – Here’s What Happened

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)’s share price rose 2% on Monday . The stock traded as high as $40.80 and last traded at $40.63. 223,775 shares traded hands during mid-day trading, an increase of 301% from the average session volume of 55,781 shares. The stock had previously closed at $39.83.

iShares Genomics Immunology and Healthcare ETF Price Performance

The company has a market cap of $277.30 million, a price-to-earnings ratio of 14.76 and a beta of 0.95. The firm has a 50 day simple moving average of $36.61 and a 200-day simple moving average of $32.48.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

An institutional investor recently bought a new stake in iShares Genomics Immunology and Healthcare ETF stock. Anchor Investment Management LLC purchased a new stake in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 2,898 shares of the company’s stock, valued at approximately $98,000.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.